A Phase I/II Trial of Radiation, Avastin and Tarceva for Resectable or Locally Advanced Pancreatic Adenocarcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Acronyms TART
- 14 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Sep 2008 New trial record.